Humoral response after a fourth dose of SARS-CoV-2 vaccine in immunocompromised patients. Results of a systematic review
S Martinelli, D Pascucci, P Laurenti - Frontiers in Public Health, 2023 - frontiersin.org
Background and objective The fourth dose the COVID-19 vaccine was first proposed to
immunocompromised patients. The aim of the article is to systematically review the literature …
immunocompromised patients. The aim of the article is to systematically review the literature …
Alternative strategies to increase the immunogenicity of COVID-19 vaccines in kidney transplant recipients not responding to two or three doses of an mRNA vaccine …
MML Kho, AL Messchendorp, SC Frölke… - The Lancet Infectious …, 2023 - thelancet.com
Background An urgent need exists to improve the suboptimal COVID-19 vaccine response
in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with …
in kidney transplant recipients (KTRs). We aimed to compare three alternative strategies with …
Immunogenicity, clinical efficacy and safety of additional second COVID‐19 booster vaccines against Omicron and its subvariants: A systematic review
S Chenchula, MB Chandra… - Reviews in Medical …, 2024 - Wiley Online Library
The Omicron variant of severe acute respiratory syndrome coronavirus 2 is a new variant of
concern (VOC) and an emerging subvariant that exhibits heightened infectivity …
concern (VOC) and an emerging subvariant that exhibits heightened infectivity …
[HTML][HTML] Age, successive waves, immunization, and mortality in elderly COVID-19 hematological patients: EPICOVIDEHA findings
G Rossi, J Salmanton-García, C Cattaneo… - International Journal of …, 2023 - Elsevier
Objectives Elderly patients with hematologic malignancies face the highest risk of severe
COVID-19 outcomes. The infection's impact on different age groups remains unstudied in …
COVID-19 outcomes. The infection's impact on different age groups remains unstudied in …
Humoral antibody response following mRNA vaccines against SARS-CoV-2 in solid organ transplant recipients; a status after a fifth and bivalent vaccine dose
E Christophorou, AC Nilsson, I Petersen… - Frontiers in …, 2023 - frontiersin.org
Background In solid organ transplant (SOT) recipients, the humoral response following
COVID-19 vaccination is reduced, as a result of their immunosuppressed treatment. In this …
COVID-19 vaccination is reduced, as a result of their immunosuppressed treatment. In this …
[HTML][HTML] Using machine learning to predict antibody response to SARS-CoV-2 vaccination in solid organ transplant recipients: the multicentre ORCHESTRA cohort
M Giannella, M Huth, E Righi, J Hasenauer… - Clinical Microbiology …, 2023 - Elsevier
Objectives The study aim was to assess predictors of negative antibody response (AbR) in
solid organ transplant (SOT) recipients after the first booster of SARS-CoV-2 vaccination …
solid organ transplant (SOT) recipients after the first booster of SARS-CoV-2 vaccination …
SARS-CoV-2 vaccination in solid-organ transplant recipients
M Peghin, E Graziano, PA Grossi - Vaccines, 2022 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic has posed significant global
challenges for solid organ transplant (SOT) recipients. Mortality rates of COVID-19 in this …
challenges for solid organ transplant (SOT) recipients. Mortality rates of COVID-19 in this …
Immune response after the fourth dose of SARS-CoV-2 mRNA vaccine compared to natural infection in three doses' vaccinated solid organ transplant recipients
R Busà, G Russelli, M Miele, MC Sorrentino, M Di Bella… - Viruses, 2022 - mdpi.com
Solid organ transplant recipients (SOTRs) show higher rates of COVID-19 breakthrough
infection than the general population, and nowadays, vaccination is the key preventative …
infection than the general population, and nowadays, vaccination is the key preventative …
The fourth dose of CoronaVac vaccine results in a small increase of seroconversion and antibody values among kidney transplant recipients
MP Cristelli, MR Nakamura, LA Viana… - …, 2022 - journals.lww.com
We recently reported that, after a homologous booster dose of CoronaVac vaccine, only
20.3% of 300 kidney transplant recipients who were seronegative before the third dose …
20.3% of 300 kidney transplant recipients who were seronegative before the third dose …
Humoral and cellular immune response and the safety of third SARS-CoV-2 mRNA vaccine with longer interval after the second vaccination in kidney transplant …
S Takai, H Nishida, H Ito, H Fukuhara… - Frontiers in …, 2022 - frontiersin.org
We evaluated the humoral and cellular immune responses and safety of the third severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine with a longer …
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mRNA vaccine with a longer …